DP
GMED icon

Dundas Partners’s Globus Medical GMED Stock Holding History

Dundas Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,713
Closed -$145K – 49
2023
Q4 		$145K Hold
2,713
– – 0.01% 43
2023
Q3 		$135K Hold
2,713
– – 0.01% 45
2023
Q2 		$162K Hold
2,713
– – 0.02% 45
2023
Q1 		$154K Sell
2,713
-193
-7% -$12.4K 0.02% 42
2022
Q4 		$216K Hold
2,906
– – 0.02% 38
2022
Q3 		$173K Hold
2,906
– – 0.02% 44
2022
Q2 		$163K Hold
2,906
– – 0.02% 46
2022
Q1 		$214K Hold
2,906
– – 0.02% 45
2021
Q4 		$204K Buy
2,906
+2,859
+6,083% +$208K 0.03% 46
2021
Q3 		$4K Buy
+47
New +$3.77K ﹤0.01% 46

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Dundas Partners's GMED Position: Q1 2024 in Review

Dundas Partners sold out of Globus Medical (GMED) in Q1 2024, closing a stake of 2,713 shares — an estimated $145K sold.

Dundas Partners first reported a position in GMED in Q3 2021 and held it in 10 quarters. The position peaked at $216K in Q4 2022. 439 funds tracked by Wall St. Rank hold GMED as of Q1 2024.

  • Dundas Partners reported no remaining Globus Medical position as of Q1 2024 after selling out during the quarter.
  • Dundas Partners sold 2,713 Globus Medical shares in Q1 2024, an estimated $145K.
  • Dundas Partners first reported a position in Globus Medical in Q3 2021 and held it in 10 quarters.
  • Dundas Partners's Globus Medical position peaked at $216K in Q4 2022.
  • 439 funds tracked by Wall St. Rank held Globus Medical as of Q1 2024.

Based on Dundas Partners's 13F filing for Q1 2024, filed 14 May 2024.